Related references
Note: Only part of the references are listed.Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
Qing Zhou et al.
BLOOD (2009)
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
Ulrich Keilholz et al.
BLOOD (2009)
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
Yongzhi Cui et al.
BLOOD (2009)
Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression
Sabine Mumprecht et al.
BLOOD (2009)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
Long Zhang et al.
BLOOD (2009)
T Cell-Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective
Alaaeldin Shablak et al.
CLINICAL CANCER RESEARCH (2009)
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Qiang Gao et al.
CLINICAL CANCER RESEARCH (2009)
B7-H1 and CD8(+) Treg: The enigmatic role of B7-H1 in peripheral tolerance
Ari Waisman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Peptide vaccines for patients with acute myeloid leukemia
Michael Schmitt et al.
EXPERT REVIEW OF VACCINES (2009)
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV
Debora Franceschini et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Molecular recognition of acute myeloid leukemia using aptamers
K. Sefah et al.
LEUKEMIA (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Human Prostate-Infiltrating CD8+ T Lymphocytes are Oligoclonal and PD-I+
Karen S. Sfanos et al.
PROSTATE (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Donor lymphocyte infusions for acute myeloid leukaemia
Robert J. Soiffer
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
FOXP3+ Tregs and B7-HI+/PD-I+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients:: Implication for immunotherapy
Hazem Ghebeh et al.
BMC CANCER (2008)
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years
Hagop Kantarjian et al.
CANCER (2008)
Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer
Martin Loos et al.
CANCER LETTERS (2008)
Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation
D. Montagna et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2008)
Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines
Liane Daudt et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Programmed death-1 as a factor in immune exhaustion and activation in HIV infection
Daniel E. Kaufmann et al.
CURRENT OPINION IN HIV AND AIDS (2008)
Programmed death-1 concentration at the immunologicial synapse is determined by ligand affinity and availability
Tsvetelina Pentcheva-Hoang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection
Katsunori Tanaka et al.
JOURNAL OF IMMUNOLOGY (2007)
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav D. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model
Kutlu G. Elpek et al.
JOURNAL OF IMMUNOLOGY (2007)
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion
Christian Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression
Henry Radziewicz et al.
JOURNAL OF VIROLOGY (2007)
Adoptive transfer of cytotoxic T-cells for treatment of residual disease after irradiation
Mechthild Krause et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2007)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day et al.
NATURE (2006)
Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells
Giorgio Raimondi et al.
JOURNAL OF IMMUNOLOGY (2006)
Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation
AW Loren et al.
CURRENT OPINION IN ONCOLOGY (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression
JP Huang et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Persistence of multiple tumor-specific T-Cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
JH Zhou et al.
JOURNAL OF IMMUNOTHERAPY (2005)
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells
YE Latchman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells
MG Sauer et al.
CANCER RESEARCH (2004)
Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses
F Tsushima et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Expression of programmed death 1 ligands by murine T cells and APC
T Yamazaki et al.
JOURNAL OF IMMUNOLOGY (2002)
Treatment of acute myeloid leukemia: State-of-the-art and future directions
RM Stone
SEMINARS IN HEMATOLOGY (2002)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
